RESUMEN
BACKGROUND: The clinicopathological parameters such as residual tumor, grade, the International Federation of Gynecology and Obstetrics (FIGO) score are often used to predict the survival of ovarian cancer patients, but the 5-year survival of high grade serous ovarian cancer (HGSOC) still remains around 30%. Hence, the relentless pursuit of enhanced prognostic tools for HGSOC, this study introduces an unprecedented gene expression-based molecular prognostic score (mPS). Derived from a novel 20-gene signature through Least Absolute Shrinkage and Selection Operator (LASSO)-Cox regression, the mPS stands out for its predictive prowess. RESULTS: Validation across diverse datasets, including training and test sets (n = 491 each) and a large HGSOC patient cohort from the Ovarian Tumor Tissue Analysis (OTTA) consortium (n = 7542), consistently shows an area-under-curve (AUC) around 0.7 for predicting 5-year overall survival. The mPS's impact on prognosis resonates profoundly, yielding an adjusted hazard-ratio (HR) of 6.1 (95% CI: 3.65-10.3; p < 0.001), overshadowing conventional parameters-FIGO score, residual disease, and age. Molecular insights gleaned from mPS stratification uncover intriguing pathways, with focal-adhesion, Wnt, and Notch signaling upregulated, and antigen processing and presentation downregulated (p < 0.001) in high-risk HGSOC cohorts. CONCLUSION: Positioned as a robust prognostic marker, the 20-gene signature-derived mPS emerges as a potential game-changer in clinical settings. Beyond its role in predicting overall survival, its implications extend to guiding alternative therapies, especially targeting Wnt/Notch signaling pathways and immune evasion-a promising avenue for improving outcomes in high-risk HGSOC patients.
Asunto(s)
Neoplasias Ováricas , Humanos , Femenino , Pronóstico , Neoplasias Ováricas/genética , Neoplasias Ováricas/patología , Neoplasias Ováricas/mortalidad , Neoplasias Ováricas/metabolismo , Clasificación del Tumor , Cistadenocarcinoma Seroso/genética , Cistadenocarcinoma Seroso/patología , Cistadenocarcinoma Seroso/mortalidad , Cistadenocarcinoma Seroso/metabolismo , Biomarcadores de Tumor/genética , Medición de Riesgo/métodos , Perfilación de la Expresión Génica , Persona de Mediana EdadRESUMEN
Monoamines are implicated in a cognitive processes in a variety of brain regions, including the hippocampal formation, where storage and retrieval of information are facilitated by synchronous network activities. We have investigated the effects of norepinephrine, serotonin, and dopamine on carbachol-, kainate-, and stimulus-induced hippocampal gamma-oscillations employing combined extra- and intracellular recordings. Monoamines dose-dependently and reversibly suppressed kainate- and carbachol-induced gamma-oscillations while increasing the frequency. The effect of serotonin was mimicked by fenfluramine, which releases serotonin from presynaptic terminals. Forskolin also suppressed kainate- and carbachol-induced gamma-oscillations. This effect was mimicked by 8-Br-cAMP and isoproterenol, an agonist of noradrenergic beta-receptor suggesting that the monoamines-mediated suppression of these oscillations could involve intracellular cyclic adenosine 3',5'-cyclic monophosphate (AMP). By contrast, stimulus-induced gamma-oscillations were dose-dependently augmented in power and duration after monoamines application. Intracellular recordings from pyramidal cells revealed that monoamines prolonged the stimulus-induced depolarization and membrane potential oscillations. Stimulus-induced gamma-oscillations were also suppressed by isoproterenol, the D1 agonist SKF-38393 forskolin, and 8-Br-cAMP. This suggests that the augmentation of stimulus-induced gamma-oscillations by monoamines involves--at least in part-different classes of cells than in case of carbachol- and kainate-induced gamma-oscillations.
Asunto(s)
Monoaminas Biogénicas/farmacología , Hipocampo/efectos de los fármacos , Hipocampo/fisiología , 2,3,4,5-Tetrahidro-7,8-dihidroxi-1-fenil-1H-3-benzazepina/farmacología , 8-Bromo Monofosfato de Adenosina Cíclica/farmacología , Animales , Carbacol/farmacología , Fármacos del Sistema Nervioso Central/farmacología , Colforsina/farmacología , Dopamina/farmacología , Estimulación Eléctrica , Fenfluramina/farmacología , Técnicas In Vitro , Isoproterenol/farmacología , Ácido Kaínico/farmacología , Potenciales de la Membrana/efectos de los fármacos , Norepinefrina/farmacología , Células Piramidales/efectos de los fármacos , Células Piramidales/fisiología , Ratas , Ratas Wistar , Serotonina/farmacología , Serotoninérgicos/farmacologíaRESUMEN
Sharp wave-ripple complexes (SPW-Rs) are characterized by approximately 60 ms field potential transients superimposed by ripple oscillations of approximately 200 Hz. In chronic epileptic rodents and humans, faster ripples have been recorded showing frequencies of up to 500 Hz. In this study, we tested whether the blockade of K currents by 4-aminopyridine (4-AP) contribute to the generation of high-frequency ripples, as changes in K channel expression have been observed in chronic epileptic tissue. We showed that 4-AP significantly increased the amplitudes and incidence of induced SPW-Rs without significantly changing their ripple frequency. alpha-Dendrotoxin or BDS-I did not mimick these changes suggesting that 4-AP acts via Kv1.4 channels. Thus, the incidence of SPW-Rs, but not the ripple frequency is regulated by 4-AP-sensitive potassium currents.